Covered recipient · General Payments record
CHIOMA UDEMGBA
Allopathic & Osteopathic Physicians Allergy & Immunology
General Payments · PY2024
$178.99
- Reported across 7 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $178.99 | 7 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $67.58 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $57.00 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.63 | 1 |
| Regeneron Healthcare Solutions, Inc. | $17.15 | 1 |
| Greer Laboratories, Inc. | $13.63 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $178.99 | 7 |
Payment records · PY2024 (7)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $21.62 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105811647 | CMS |
| AstraZeneca Pharmaceuticals LP | $24.53 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104680323 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.43 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104626942 | CMS |
| Greer Laboratories, Inc. | $13.63 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131112870 | CMS |
| Novartis Pharmaceuticals Corporation | $57.00 | 10/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087440250 | CMS |
| Regeneron Healthcare Solutions, Inc. | $17.15 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114228472 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $23.63 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137690411 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.